Search clinical trials for: LY900014-U100

Total 2291 results

Eli Lilly and Company

Completed

A Study to Compare 2 Formulations of LY900014 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

Study to Compare 2 Formulations of LY900014 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY900014 Formulation at Different Injection Sites in Healthy Participants

Diabetes Mellitus, Type 2

Singapore
Eli Lilly and Company

Completed

A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

Notch Inhibitor in Advanced Cancer

Advanced Cancer

United States
MedtronicNeuro

Completed

Study of Weight Loss Using Gastric Stimulation in Obese Patients With Type 2 Diabetes (ASSIST)

Severe to Morbid Obesity and Type 2 Diabetes

United States
Sanofi

Completed

Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With Lantus

Type 1 Diabetes Mellitus

Germany
Eli Lilly and Company

Completed

A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes

Diabetes Mellitus, Type 1

Canada
Eli Lilly and Company

Completed

A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)

Type 2 Diabetes

United States, Puerto Rico
Eli Lilly and Company

Completed

A Study of LY900014 in Participants With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Canada, Germany
Eli Lilly and Company

Completed

A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes

Type 1 Diabetes

United States
Eli Lilly and Company

Completed

A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps

Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company

Completed

A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company

Completed

A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Japan
Eli Lilly and Company

Completed

A Study of LY900014 Formulation in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps

Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company

Completed

A Study of LY900014 in a Medtronic Pump

Type1 Diabetes Mellitus

United States
Eli Lilly and Company

Completed

A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM)

Diabetes Mellitus, Type 2

Germany
Eli Lilly and Company

Completed

A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes (PRONTO-Pump)

Diabetes Type 1

United States, Spain
Boston Children's Hospital
United States Department of Defense; National Football League

Completed

LED Therapy for the Treatment of Concussive Brain Injury

Brain Concussion

United States
Sanofi

Completed

A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

United States, Puerto Rico
Eli Lilly and Company

Completed

A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy

Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company

Completed

A Study of LY900014 Formulations in Healthy Participants

Healthy Volunteers

Singapore
Eli Lilly and Company

Completed

A Study of LY900014 in Participants With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Germany
Eli Lilly and Company

Completed

A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants

Diabetes Mellitus, Type 2

Germany
Eli Lilly and Company

Completed

A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company

Completed

A Study of a New LY900014 Formulation in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY900014 in Healthy Chinese Participants

Healthy

China
Eli Lilly and Company

Completed

A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy

Diabetes Mellitus, Type 2

Germany
Eli Lilly and Company

Completed

A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants

Healthy

Japan
Eli Lilly and Company

Completed

A Study of Various Formulations of LY900014 in Healthy Participants

Healthy

Singapore
Eli Lilly and Company

Completed

A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump

Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company

Completed

A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States, France, Germany, Taiwan, Spain, Belgium, Switzerland, Netherlands, Russian Federation, South Africa, Poland, Hungary, Italy, Norway, India, Sweden, Argentina, United Kingdom, Puerto Rico, Chile, Romania
Emory University

Completed

Glargine U300 Hospital Trial

Type 2 Diabetes

United States
Eli Lilly and Company

Completed

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes

Type 1 Diabetes Mellitus

China, Argentina, Mexico
Eli Lilly and Company

Completed

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes

Type 2 Diabetes Mellitus

China, Mexico, Argentina
Eli Lilly and Company

Completed

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes (PRONTO-Peds)

Type 1 Diabetes Mellitus

United States, Czechia, France, Spain, Japan, Germany, Italy, Brazil, Denmark, Austria, United Kingdom, China, Russian Federation, Mexico, Poland, Ukraine, Israel, Puerto Rico
Eli Lilly and Company

Completed

A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company
Locemia Solutions ULC

Completed

A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Canada
Eli Lilly and Company
Cipla Ltd.

Recruiting

A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India

Diabetes Mellitus, Type 2

India
Eli Lilly and Company
Locemia Solutions ULC

Terminated

A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Canada
Eli Lilly and Company

Completed

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy (PRONTO-Pump-2)

Type 1 Diabetes Mellitus

Spain, United States, France, Israel, Australia, Germany, Italy, Puerto Rico, Austria, Hungary, Canada
Eli Lilly and Company

Completed

A Study of Axiron® in Healthy Participants

Healthy Volunteers

United States
Eli Lilly and Company

Completed

A Study of LY900014 in Participants With Type 1 Diabetes (PRONTO-T1D)

Type 1 Diabetes Mellitus

Italy, Japan, United States, Puerto Rico, Spain, Taiwan, Mexico, Austria, Germany, Poland, New Zealand, Romania, Russian Federation, Argentina, India, Sweden, Slovakia, Australia, Brazil, Greece
Sanofi

Completed

Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications (SENIOR)

Type 2 Diabetes Mellitus

United States, Australia, Spain, Korea, Republic of, Hungary, Mexico, Italy, Poland, Argentina, Canada, Colombia, France, Germany, Japan, Peru, Romania, Sweden, United Kingdom
Eli Lilly and Company

Completed

A Bioavailability Study of LY2452473 and Tadalafil

Erectile Dysfunction

United States
Eli Lilly and Company

Completed

A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes (RescuiNGkids)

Type 1 Diabetes

United States
Eli Lilly and Company

Completed

A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels

Hypogonadism | Ejaculatory Dysfunction

United States, Canada
G&E Herbal Biotechnology Co., LTD

Completed

Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis (AK)

Actinic Keratosis | Bowen's Disease

Taiwan
Eli Lilly and Company

Completed

A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations

Hypogonadism

United States

Search clinical trials for: LY900014-U100

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations